1-11 of 11
Brandon Hayes-Lattin, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T-Cell Suppression By Src/ABL Kinase Inhibitors When Combined with Blinatumomab in Ph+ Acute Lymphoblastic Leukemia

Jessica Leonard, MD, Yoko Kosaka, PhD, Pavani Malla, MS, Brandon Hayes-Lattin, MD, Adam J. Lamble, MD, Brian J. Druker, MD, Jeffrey W. Tyner, PhD, Bill H. Chang, MD PhD, Evan F. Lind, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2694.
https://doi.org/10.1182/blood-2018-99-119301
Published: 2018
Journal Articles

Thromboprophylaxis with Fixed Dose, 1mg/Kg/Day, Low Molecular Weight Heparin in Adults Undergoing Induction with Asparaginase for Acute Lymphoblastic Leukemia. Results of a Single Institution Cohort Study

Luai S Al Rabadi, MD, Sven Reid Olson, MD, Joseph J. Shatzel, MD, Thomas G. Deloughery, MD MACP, FAWM, Brandon Hayes-Lattin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2397.
https://doi.org/10.1182/blood.V130.Suppl_1.2397.2397
Published: 2017
Journal Articles

Novel Targets Identified By in Vitro Screening of Patient Samples with Adult Acute Lymphoblastic Leukemia

Jessica T Leonard, MD, Bill H. Chang, MD PhD, Jeffrey W. Tyner, PhD, Brandon Hayes-Lattin, MD, Marc M. Loriaux, Brian J. Druker, Uma Borate, MD
Journal: Blood
Blood (2016) 128 (22): 2811.
https://doi.org/10.1182/blood.V128.22.2811.2811
Published: 2016
Journal Articles

Dual Targeting of Ph+ ALL with Dasatinib and ABT-199 (Venetoclax)

Jessica Leonard, MD, Joelle Rowley, Brandon Hayes-Lattin, MD, Jeffrey W. Tyner, PhD, Marc Loriaux, MD PhD, Brian J. Druker, MD, Bill H Chang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1329.
https://doi.org/10.1182/blood.V126.23.1329.1329
Published: 2015
Journal Articles

Improved Outcome with Busulfan, Melphalan, and Thiotepa Conditioning (BuMelTt) in Autologous Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma

Tarunpreet Bains, MD, Andy I Chen, MD, PhD, Andrew Lemieux, BS, Brandon Hayes-Lattin, MD, Jose F. Leis, MD, PhD, Richard T Maziarz, MD
Journal: Blood
Blood (2011) 118 (21): 3110.
https://doi.org/10.1182/blood.V118.21.3110.3110
Published: 2011
Journal Articles

BMT CTN 0302: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox, and Pentostatin in Combination with Corticosteroids in 180 Patients (pts) with Newly Diagnosed Acute Graft Vs. Host Disease (aGVHD)

Amin Alousi, MD, Daniel J. Weisdorf, MD, Brent R. Logan, PhD, Javier Bolanos-Meade, MD, Steven C. Goldstein, MD, Vincent T Ho, MD, Brandon Hayes-Lattin, MD, John R. Wingard, MD, Mary M. Horowitz, MD, MS, John E. Levine, MD, MS
Journal: Blood
Blood (2008) 112 (11): 55.
https://doi.org/10.1182/blood.V112.11.55.55
Published: 2008
Journal Articles

Superior Survival after Autologous vs. Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Diffuse Large B-Cell Lymphoma (DLBCL) Not Explained by Differences in Chemosensitivity.

Brandon Hayes-Lattin, MD, Jeanette Carreras, MPH, Mei-Jie Zhang, PhD, Koen van Besien, MD, Julie M. Vose, MD, Hillard M. Lazarus, MD, J. Douglas Rizzo, MD, MS, Parameswaran Hari, MD
Journal: Blood
Blood (2006) 108 (11): 3021.
https://doi.org/10.1182/blood.V108.11.3021.3021
Published: 2006
Journal Articles

Rescue from Failed Growth Factor and/or Chemotherapy HSC Mobilization with G-CSF and AMD3100: An Institutional Experience.

Richard Thomas Maziarz, MD, Adam Dunn, BS, Lisa Hansen, RN, Keith Hansen, MD, Jose F. Leis, MD, PhD, Brandon Hayes-Lattin, MD, Tibor Kovacsovics, MD, Gary Calandra, MD, Cedar Fowler, BA
Journal: Blood
Blood (2006) 108 (11): 5460.
https://doi.org/10.1182/blood.V108.11.5460.5460
Published: 2006
Journal Articles

A Phase II Study of Xcellerated T Cells™ in Patients with Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma (NHL).

Nancy L. Bartlett, MD, John G. Gribben, MD, DSc, Ralph V. Boccia, MD, FACP, Michael S. Milder, MD, David M. Aboulafia, MD, Januario Castro, MD, Ian Flinn, MD, PhD, Brandon Hayes-Lattin, MD, Lawrence Kaplan, MD, Thomas Lin, MD, Jennifer B. Lucas, MD, David G. Maloney, MD, Peter McLaughlin, MD, Peter A. McSweeney, MD, Ann Mohrbacher, MD, Charles Redfern, MD, Ronald Steis, MD, Joe J. Stephenson, MD, Roger Strair, MD, Ronald J. Berenson, MD, Mark W. Frohlich, MD
Journal: Blood
Blood (2004) 104 (11): 4640.
https://doi.org/10.1182/blood.V104.11.4640.4640
Published: 2004
Journal Articles

Survival after Autologous Transplantation to Treat Diffuse Large B-Cell Lymphoma with a History of CNS Involvement, Bone Marrow Involvement, or Histologic Transformation.

Brandon Hayes-Lattin, MD, Pritesh Mehta, Adam Dunn, Nan Subbiah, Jose F. Leis, MD, PhD, Aleksandra Simic, MD, Bryon Allen, Suzanne Balliesen, Peter T. Curtin, MD, Elliot Epner, MD, PhD, William H. Fleming, MD, PhD, Carol Jacoby, Michael J. Mauro, MD, Craig R. Nichols, MD, Susan Schubach, Richard T. Maziarz, MD
Journal: Blood
Blood (2004) 104 (11): 5237.
https://doi.org/10.1182/blood.V104.11.5237.5237
Published: 2004
Journal Articles

Safety and Tolerability of Anti-Bacterial Prophylaxis during the Post-Engraftment Phase after Myeloablative Hematopoietic Stem Cell Transplantation.

Brandon Hayes-Lattin, MD, Joseph Bubalo, PharmD, Adam Dunn, Nan Subbiah, Bryon Allen, Suzanne Balleisen, Peter T. Curtin, MD, Carol Jacoby, Jose F. Leis, MD, PhD, Michael J. Mauro, MD, Aleksandra Simic, MD, Susan Schubach, Richard T. Maziarz, MD
Journal: Blood
Blood (2004) 104 (11): 5093.
https://doi.org/10.1182/blood.V104.11.5093.5093
Published: 2004